Despite a few cases of long-responder patients, immunotherapy with anti-PD-(L)1 has so far proved rather disappointing in monotherapy in metastatic breast cancer, prompting the use of synergistic therapeutic combinations incorporating immunotherapy by immune-checkpoint inhibitors. In addition, a better understanding of both the mechanisms of sensitivity and resistance to immunotherapy, as well as the immunological effects of the usual treatments for breast cancer, make it possible to rationally consider this type of therapeutic combination. For several years, certain treatments, commonly used to treat patients with breast cancer, have shown that in addition to their direct cytotoxic effects, they may have an impact on the tumor immune microenvironment, by increasing the antigenicity and/or immunogenicity of a “cold” tumor, targeting the immunosuppressive microenvironment or counteracting the immune-exclusion profile. This review focuses on preclinical immunologic synergic mechanisms of various standard therapeutic approaches with anti-PD-(L)1, and discusses the potential clinical use of anti-PD-1/L1 combinations in metastatic or early breast cancer.
Cancers, Free Full-Text, scp 666 1/2 j
100% Cancer Free sticker — Perch Handmade
Evans Syndrome In Dogs Survival Rate Deals
Cancer Survivor Card for All Clear. 'those Magic Words 'all Clear
5 Years Throat Cancer Free Throat Cancer Survivor' Full Color Mug
Cancers, Free Full-Text
All cancers Vectors & Illustrations for Free Download
Inter-Breath-Hold Geometric and Dosimetric Variations in Organs at
The Imaginary Journal of Poetic Economics: Cancer Literature: 13% Free
Cancers, Free Full-Text, sonic sprites modgen
Cancer Awareness Message in EPS, Illustrator, JPEG, Word, PSD, PNG
Cancers, Free Full-Text
Buy Ring The Bell, I Am Cancer Free Book Online at Low Prices in
Cancers, Free Full-Text, jack smith ferreiro